{
  "study": {
    "study_id": "Velin2021-Rwanda-KireheDistrictHospital-2019_2020-01",
    "title": "Surgical Site Infections and Antimicrobial Resistance After Cesarean Section Delivery in Rural Rwanda",
    "authors": [
      "Lotta Velin",
      "Grace Umutesi",
      "Robert Riviello",
      "Moses Muwanguzi",
      "Lisa M. Bebell",
      "Marthe Yankurije",
      "Kara Faktor",
      "Theoneste Nkurunziza",
      "Gilbert Rukundo",
      "Jean de Dieu Gatete",
      "Ivan Emil",
      "Bethany L. Hedt-Gauthier",
      "Fredrick Kateera"
    ],
    "journal": "Annals of Global Health",
    "year_publication": 2021,
    "doi": "10.5334/aogh.3413",
    "country_list": [
      "Rwanda"
    ],
    "country_iso3": "RWA",
    "region_classification": "ECSA",
    "surgical_specialty": [
      "obstetrics/gynecology"
    ],
    "language": "English",
    "data_source_type": "published_full_text",
    "ownership_type": "public",
    "surgical_volume_per_year": 2715
  },
  "design": {
    "study_design": "cohort",
    "randomized": false,
    "prospective": true,
    "single_center": true,
    "multi_center": false,
    "inclusion_criteria_text": "All women who delivered via c-section at Kirehe District Hospital between September 23, 2019, and March 16, 2020, except for December 16â€“28, when study activities ceased due to the holiday season. Women from Mahama Refugee Camp were excluded.",
    "exclusion_criteria_text": "Women from Mahama Refugee Camp due to inability to complete study activities; women unable to attend follow-up due to COVID-19 restrictions.",
    "sample_frame": "patients",
    "unit_of_analysis": "patient",
    "duplicate_publication_likelihood": false
  },
  "setting": {
    "facility_level": "secondary",
    "urban_rural": "rural",
    "care_setting": "hospital",
    "country_specific_sites": [
      "Kirehe District Hospital, Eastern Province, Rwanda"
    ]
  },
  "eligibility": {
    "population": "Women who delivered via cesarean section at Kirehe District Hospital during the study period.",
    "classification": "adult",
    "intervention": "Pre- and post-operative antibiotic use; standard prophylaxis and treatment regimens as per local practice.",
    "comparator": "None specified.",
    "outcomes_reported": [
      "ssi_incidence",
      "amr_prevalence",
      "morbidity"
    ],
    "timeframe_years": "September 23, 2019 to March 16, 2020",
    "setting_types": [
      "hospital",
      "surgical_unit"
    ],
    "included_designs": [
      "cohort"
    ],
    "excluded_designs": []
  },
  "timeframe": {
    "data_collection_start_year": 2019,
    "data_collection_start_month": 9,
    "data_collection_end_year": 2020,
    "data_collection_end_month": 3,
    "follow_up_window_days": 11
  },
  "populations": [
    {
      "arm_id": "overall",
      "description": "All women who delivered via c-section at Kirehe District Hospital and completed POD 11 follow-up.",
      "n_participants": 795,
      "n_procedures": 795,
      "age_group": "adult",
      "elective_emergency": "unspecified",
      "wound_class": "unspecified",
      "comorbidities_key": "HIV seroprevalence 0.7%; majority in Ubudehe category 1 or 2 (61.6%)",
      "surgical_specialties": [
        "obstetrics/gynecology"
      ],
      "provenance": {
        "page": 4,
        "section_heading": "RESULTS",
        "text_snippet": "A total of 930 women were enrolled in the study, of whom 85.5% (n = 795) completed the POD 11 study clinic visit."
      }
    }
  ],
  "definitions": {
    "ssi_definition_standard": [
      "CDC_NHSN"
    ],
    "ssi_window_days": 11,
    "amr_definition_standard": [
      "study_defined"
    ],
    "resistance_definition_text": "Intermediate or resistant as per NRL standard operating procedures using VITEK2 system.",
    "outcome_definitions_text": "SSI defined per CDC guidelines; superficial and deep SSI classified; morbidity includes other post-operative complications (hematoma).",
    "specimen_type": [
      "wound_swab"
    ]
  },
  "lab_methods": {
    "specimen_collection_method": "Levine technique: sterile rayon-tipped swab applied to clean viable tissue at deepest accessible part of wound after irrigation with sterile saline.",
    "culture_method": "Initial microbiology cultures on blood agar plates prepared with human blood; colony morphology, Gram stain, and VITEK2 system for identification.",
    "AST_method": [
      "automated"
    ],
    "QC_measures": "Laboratory technician trained in preparation of agar plates, Gram stains, bacterial growth analysis, and safe transportation of biohazard materials.",
    "organism_identification_method": "Colony morphology, Gram stain, VITEK2 testing system.",
    "contamination_handling": "Potential contaminants (CoNS, Lactococcus, Kocuria) noted; semi-sterile technique used.",
    "lab_capacity_notes": "Blood agar prepared with human blood due to lack of sheep's blood; NRL standard practice."
  },
  "outcomes": {
    "ssi_incidence": [
      {
        "arm_id": "overall",
        "surgical_specialty": "obstetrics/gynecology",
        "denominator_type": "patients",
        "ssi_type": "overall",
        "n_ssi_events": 45,
        "n_total": 795,
        "rate_as_reported": {
          "value": 5.7,
          "unit": "percent"
        },
        "ascertainment_window_days": 11,
        "data_period": {
          "start_year": 2019,
          "end_year": 2020
        },
        "subgroup_labels": {
          "country": "Rwanda",
          "facility_level": "secondary",
          "setting": "hospital"
        },
        "notes": "SSI diagnosis at POD 11 (+/- 3 days); 40 superficial, 5 deep.",
        "provenance": {
          "page": 4,
          "section_heading": "DETAILS OF SURGICAL SITE INFECTIONS",
          "table_id": "Table 1",
          "text_snippet": "Among the 795 women who completed the POD 11 study visit, 45 (5.7%) were diagnosed with an SSI."
        }
      }
    ],
    "amr_proportions": [
      {
        "arm_id": "overall",
        "pathogen": "Escherichia coli",
        "antibiotic": "ceftriaxone",
        "who_class": "critically_important",
        "n_tested": 3,
        "n_resistant": 3,
        "n_susceptible": 0,
        "ast_method": "VITEK2",
        "breakpoint_standard": "study_defined",
        "specimen_type": "wound_swab",
        "site": "surgical site",
        "data_period": {
          "start_year": 2019,
          "end_year": 2020
        },
        "notes": "100% intermediate or resistant to ceftriaxone.",
        "provenance": {
          "page": 5,
          "section_heading": "Table 2",
          "table_id": "Table 2",
          "text_snippet": "E. coli (n = 3)\n100"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Klebsiella pneumoniae",
        "antibiotic": "ceftriaxone",
        "who_class": "critically_important",
        "n_tested": 8,
        "n_resistant": 8,
        "n_susceptible": 0,
        "ast_method": "VITEK2",
        "breakpoint_standard": "study_defined",
        "specimen_type": "wound_swab",
        "site": "surgical site",
        "data_period": {
          "start_year": 2019,
          "end_year": 2020
        },
        "notes": "100% intermediate or resistant to ceftriaxone.",
        "provenance": {
          "page": 5,
          "section_heading": "Table 2",
          "table_id": "Table 2",
          "text_snippet": "K. pneumoniae (n = 8)\n100"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Proteus spp.",
        "antibiotic": "ceftriaxone",
        "who_class": "critically_important",
        "n_tested": 8,
        "n_resistant": 7,
        "n_susceptible": 1,
        "ast_method": "VITEK2",
        "breakpoint_standard": "study_defined",
        "specimen_type": "wound_swab",
        "site": "surgical site",
        "data_period": {
          "start_year": 2019,
          "end_year": 2020
        },
        "notes": "88% intermediate or resistant to ceftriaxone.",
        "provenance": {
          "page": 5,
          "section_heading": "Table 2",
          "table_id": "Table 2",
          "text_snippet": "Proteus. spp (n = 8)\n88"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Enterobacter cloacae complex",
        "antibiotic": "ceftriaxone",
        "who_class": "critically_important",
        "n_tested": 8,
        "n_resistant": 8,
        "n_susceptible": 0,
        "ast_method": "VITEK2",
        "breakpoint_standard": "study_defined",
        "specimen_type": "wound_swab",
        "site": "surgical site",
        "data_period": {
          "start_year": 2019,
          "end_year": 2020
        },
        "notes": "100% intermediate or resistant to ceftriaxone.",
        "provenance": {
          "page": 5,
          "section_heading": "Table 2",
          "table_id": "Table 2",
          "text_snippet": "E. cloacae complex (n = 8)\n100"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Acinetobacter baumannii complex",
        "antibiotic": "ceftriaxone",
        "who_class": "critically_important",
        "n_tested": 9,
        "n_resistant": 9,
        "n_susceptible": 0,
        "ast_method": "VITEK2",
        "breakpoint_standard": "study_defined",
        "specimen_type": "wound_swab",
        "site": "surgical site",
        "data_period": {
          "start_year": 2019,
          "end_year": 2020
        },
        "notes": "100% intermediate or resistant to ceftriaxone.",
        "provenance": {
          "page": 5,
          "section_heading": "Table 2",
          "table_id": "Table 2",
          "text_snippet": "A. baumanii complex (n = 9)\n100"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Staphylococcus aureus",
        "antibiotic": "cefoxitin",
        "who_class": "critically_important",
        "n_tested": 2,
        "n_resistant": 2,
        "n_susceptible": 0,
        "ast_method": "VITEK2",
        "breakpoint_standard": "study_defined",
        "specimen_type": "wound_swab",
        "site": "surgical site",
        "data_period": {
          "start_year": 2019,
          "end_year": 2020
        },
        "mdr_definition_text": "MRSA defined as resistance to cefoxitin.",
        "mrsa_detection_method": "cefoxitin resistance by VITEK2",
        "notes": "Both S. aureus isolates were MRSA.",
        "provenance": {
          "page": 6,
          "section_heading": "Table 3",
          "table_id": "Table 3",
          "text_snippet": "S. aureus (n = 2)\n100"
        }
      }
    ],
    "morbidity": [
      {
        "measure": "complications_other",
        "n_events": 3,
        "n_total": 45,
        "definition_text": "Other post-operative complication: hematoma.",
        "subgroup_labels": {
          "country": "Rwanda",
          "facility_level": "secondary",
          "setting": "hospital"
        },
        "notes": "3/45 SSI patients had hematoma.",
        "provenance": {
          "page": 5,
          "section_heading": "Table 1",
          "table_id": "Table 1",
          "text_snippet": "Hematoma\n3 (6.8)"
        }
      }
    ],
    "mortality": [],
    "reoperations": [],
    "readmissions": [],
    "length_of_stay": [],
    "costs": [],
    "risk_factors_effects": []
  },
  "interventions": [
    {
      "type": "antibiotic_prophylaxis_protocol",
      "description": "Preoperative antibiotics given to 88.8% of participants, most commonly ampicillin. Postoperative antibiotics prescribed to 95.9%, most commonly ampicillin, gentamicin, metronidazole, and ceftriaxone.",
      "implementation_level": "facility",
      "outcomes_measured": [
        "ssi_incidence",
        "amr_prevalence"
      ],
      "effect_direction": "unclear",
      "provenance": {
        "page": 4,
        "section_heading": "Antibiotic prescriptions",
        "text_snippet": "Preoperative antibiotics were given to 88.8% (n = 815) of the participants, most commonly ampicillin (n = 766, 94.0%). Postoperative antibiotics were prescribed to 95.9% (n = 883), most commonly ampicillin (n = 486, 52.3%), followed by gentamicin (n = 447, 48.1%), metronidazole (n = 431, 46.3%), and ceftriaxone (n = 384, 41.3%)."
      }
    }
  ],
  "stewardship_guidelines": [],
  "policy_capacity": [],
  "qualitative_thematic": {
    "codes": [
      {
        "theme": "burden_incidence",
        "subtheme": "epidemiology of SSI",
        "summary": "SSI incidence after cesarean section in rural Rwanda was 5.7% at POD 11, with most infections being superficial.",
        "evidence_quotes": [
          {
            "quote": "Among the 795 women who completed the POD 11 study visit, 45 (5.7%) were diagnosed with an SSI. Most (n = 40, 88.9%) SSIs were described as superficial, and five (11.1%) were deep.",
            "page": 4,
            "section": "DETAILS OF SURGICAL SITE INFECTIONS"
          }
        ],
        "location_context": "Kirehe District Hospital, Rwanda",
        "confidence": "high",
        "provenance": {
          "page": 4,
          "section_heading": "DETAILS OF SURGICAL SITE INFECTIONS",
          "table_id": "Table 1",
          "text_snippet": "Among the 795 women who completed the POD 11 study visit, 45 (5.7%) were diagnosed with an SSI."
        }
      },
      {
        "theme": "amr_prevalence",
        "subtheme": "resistance patterns and rates by pathogen/antibiotic",
        "summary": "Gram-negative pathogens predominated in SSI wound cultures and showed high rates of resistance to commonly used antibiotics, including universal resistance to ampicillin and high resistance to ceftriaxone and cefepime.",
        "evidence_quotes": [
          {
            "quote": "No gram-negative pathogens isolated were susceptible to ampicillin, and the vast majority demonstrated intermediate susceptibility or resistance to ceftriaxone (92.1%) and cefepime (84.6%).",
            "page": 1,
            "section": "ABSTRACT"
          }
        ],
        "location_context": "Kirehe District Hospital, Rwanda",
        "confidence": "high",
        "provenance": {
          "page": 1,
          "section_heading": "ABSTRACT",
          "text_snippet": "No gram-negative pathogens isolated were susceptible to ampicillin, and the vast majority demonstrated intermediate susceptibility or resistance to ceftriaxone (92.1%) and cefepime (84.6%)."
        }
      },
      {
        "theme": "drivers_amr",
        "subtheme": "inappropriate use",
        "summary": "Universal ampicillin resistance may be due to its frequent use pre- and post-operatively, suggesting antibiotic selection pressure.",
        "evidence_quotes": [
          {
            "quote": "Universal ampicillin resistance among bacterial SSI isolates in this study may be a result of its long-term and frequent use preoperatively, and could indicate the need to reconsider its use as a post-operative prescription also, as it is likely adding to further resistanceâ€“with limited clinical benefit.",
            "page": 7,
            "section": "DISCUSSION"
          }
        ],
        "location_context": "Kirehe District Hospital, Rwanda",
        "confidence": "moderate",
        "provenance": {
          "page": 7,
          "section_heading": "DISCUSSION",
          "text_snippet": "Universal ampicillin resistance among bacterial SSI isolates in this study may be a result of its long-term and frequent use preoperatively..."
        }
      },
      {
        "theme": "prevention_control",
        "subtheme": "surveillance practices",
        "summary": "SSI diagnosis was performed at POD 11 (+/- 3 days) using CDC guidelines and trained GPs, with wound swabs collected for microbiology.",
        "evidence_quotes": [
          {
            "quote": "Before commencing data collection, two study GPs were trained to diagnose SSIs using the Center for Disease Control and Prevention guidelines [25] and to collect swabs.",
            "page": 3,
            "section": "STUDY POPULATION, DATA AND SAMPLE COLLECTION"
          }
        ],
        "location_context": "Kirehe District Hospital, Rwanda",
        "confidence": "high",
        "provenance": {
          "page": 3,
          "section_heading": "STUDY POPULATION, DATA AND SAMPLE COLLECTION",
          "text_snippet": "two study GPs were trained to diagnose SSIs using the Center for Disease Control and Prevention guidelines [25] and to collect swabs."
        }
      },
      {
        "theme": "microbiology_diagnostics",
        "subtheme": "lab capacity, methods",
        "summary": "Microbiology cultures and AST were performed at the National Reference Laboratory using VITEK2; blood agar was prepared with human blood due to lack of sheep's blood.",
        "evidence_quotes": [
          {
            "quote": "Due to difficulties procuring sheepâ€™s blood in Rwanda, human blood obtained from the National Transfusion Center was used to prepare blood agar plates, following NRL standard practice.",
            "page": 4,
            "section": "TRANSPORT AND PROCESSING OF SAMPLES"
          }
        ],
        "location_context": "National Reference Laboratory, Kigali, Rwanda",
        "confidence": "high",
        "provenance": {
          "page": 4,
          "section_heading": "TRANSPORT AND PROCESSING OF SAMPLES",
          "text_snippet": "human blood obtained from the National Transfusion Center was used to prepare blood agar plates, following NRL standard practice."
        }
      },
      {
        "theme": "evidence_gaps",
        "subtheme": "explicit gaps and research priorities",
        "summary": "Additional research is needed to determine risk factors contributing to high prevalence of gram-negative and resistant pathogens in rural Rwanda.",
        "evidence_quotes": [
          {
            "quote": "Additional research is needed to determine risk factors contributing to the high prevalence of gram-negative and resistant pathogens identified in order to guide context-appropriate care and mitigate infection risks.",
            "page": 8,
            "section": "CONCLUSIONS"
          }
        ],
        "location_context": "Kirehe District Hospital, Rwanda",
        "confidence": "high",
        "provenance": {
          "page": 8,
          "section_heading": "CONCLUSIONS",
          "text_snippet": "Additional research is needed to determine risk factors contributing to the high prevalence of gram-negative and resistant pathogens identified..."
        }
      }
    ]
  },
  "risk_of_bias": {
    "tool_used": "not_reported",
    "domain_judgements": {},
    "overall_judgement": "not_reported",
    "provenance": {}
  },
  "funding_conflicts": {
    "funding_sources": [
      "National Institutes of Health (NIH R21TW011229)",
      "William F. Milton Fund",
      "Harvard Medical School Center for Global Health Deliveryâ€“Dubai",
      "Partners In Health-Rwanda",
      "National Institutes of Health (NIH K23AI138856) for Lisa Bebell"
    ],
    "conflicts_of_interest": "The authors have no competing interests to declare.",
    "provenance": {
      "page": 8,
      "section_heading": "FUNDING INFORMATION",
      "text_snippet": "This work was supported by the National Institutes of Health (NIH R21TW011229); the William F. Milton Fund; and the Harvard Medical School Center for Global Health Deliveryâ€“Dubai."
    }
  },
  "notes_flags": [
    {
      "type": [
        "missing_data"
      ],
      "detail": "No data on mortality, reoperations, readmissions, length of stay, costs, or advanced AMR metrics (MDR/XDR, ESBL, carbapenemase) reported.",
      "provenance": {}
    },
    {
      "type": [
        "unit_unclear"
      ],
      "detail": "SSI ascertainment window is 11 days (POD 11), not standard 30 or 90 days.",
      "provenance": {
        "page": 3,
        "section_heading": "STUDY POPULATION, DATA AND SAMPLE COLLECTION",
        "text_snippet": "At discharge, an appointment was scheduled for the study clinic (Figure 1) for POD 11 (+/âˆ’ 3 days)."
      }
    }
  ],
  "provenance_index": [
    {
      "page": 1,
      "section_heading": "ABSTRACT",
      "text_snippet": "No gram-negative pathogens isolated were susceptible to ampicillin, and the vast majority demonstrated intermediate susceptibility or resistance to ceftriaxone (92.1%) and cefepime (84.6%)."
    },
    {
      "page": 4,
      "section_heading": "RESULTS",
      "text_snippet": "A total of 930 women were enrolled in the study, of whom 85.5% (n = 795) completed the POD 11 study clinic visit."
    },
    {
      "page": 4,
      "section_heading": "DETAILS OF SURGICAL SITE INFECTIONS",
      "table_id": "Table 1",
      "text_snippet": "Among the 795 women who completed the POD 11 study visit, 45 (5.7%) were diagnosed with an SSI."
    },
    {
      "page": 5,
      "section_heading": "Table 2",
      "table_id": "Table 2",
      "text_snippet": "E. coli (n = 3)\n100"
    },
    {
      "page": 5,
      "section_heading": "Table 2",
      "table_id": "Table 2",
      "text_snippet": "K. pneumoniae (n = 8)\n100"
    },
    {
      "page": 5,
      "section_heading": "Table 2",
      "table_id": "Table 2",
      "text_snippet": "Proteus. spp (n = 8)\n88"
    },
    {
      "page": 5,
      "section_heading": "Table 2",
      "table_id": "Table 2",
      "text_snippet": "E. cloacae complex (n = 8)\n100"
    },
    {
      "page": 5,
      "section_heading": "Table 2",
      "table_id": "Table 2",
      "text_snippet": "A. baumanii complex (n = 9)\n100"
    },
    {
      "page": 6,
      "section_heading": "Table 3",
      "table_id": "Table 3",
      "text_snippet": "S. aureus (n = 2)\n100"
    },
    {
      "page": 5,
      "section_heading": "Table 1",
      "table_id": "Table 1",
      "text_snippet": "Hematoma\n3 (6.8)"
    },
    {
      "page": 4,
      "section_heading": "Antibiotic prescriptions",
      "text_snippet": "Preoperative antibiotics were given to 88.8% (n = 815) of the participants, most commonly ampicillin (n = 766, 94.0%). Postoperative antibiotics were prescribed to 95.9% (n = 883), most commonly ampicillin (n = 486, 52.3%), followed by gentamicin (n = 447, 48.1%), metronidazole (n = 431, 46.3%), and ceftriaxone (n = 384, 41.3%)."
    },
    {
      "page": 3,
      "section_heading": "STUDY POPULATION, DATA AND SAMPLE COLLECTION",
      "text_snippet": "two study GPs were trained to diagnose SSIs using the Center for Disease Control and Prevention guidelines [25] and to collect swabs."
    },
    {
      "page": 4,
      "section_heading": "TRANSPORT AND PROCESSING OF SAMPLES",
      "text_snippet": "human blood obtained from the National Transfusion Center was used to prepare blood agar plates, following NRL standard practice."
    },
    {
      "page": 7,
      "section_heading": "DISCUSSION",
      "text_snippet": "Universal ampicillin resistance among bacterial SSI isolates in this study may be a result of its long-term and frequent use preoperatively..."
    },
    {
      "page": 8,
      "section_heading": "CONCLUSIONS",
      "text_snippet": "Additional research is needed to determine risk factors contributing to the high prevalence of gram-negative and resistant pathogens identified..."
    },
    {
      "page": 8,
      "section_heading": "FUNDING INFORMATION",
      "text_snippet": "This work was supported by the National Institutes of Health (NIH R21TW011229); the William F. Milton Fund; and the Harvard Medical School Center for Global Health Deliveryâ€“Dubai."
    }
  ],
  "extraction_summary": {
    "completeness_score": 80,
    "missing_fields": [
      "bed_capacity",
      "length_of_stay",
      "costs",
      "mortality",
      "reoperations",
      "readmissions",
      "advanced AMR metrics (MDR/XDR, ESBL, carbapenemase)",
      "stewardship_guidelines",
      "policy_capacity",
      "qualitative method context",
      "risk_of_bias tool and domains"
    ],
    "parser_warnings": [
      "No data on mortality, LOS, costs, or advanced AMR metrics.",
      "SSI ascertainment window is 11 days, not standard 30/90 days.",
      "No explicit risk of bias assessment reported."
    ],
    "confidence_overall": "high"
  }
}